Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
ULK-101 is an inhibitor of unc-51-like autophagy activating kinase 1 (ULK1) and ULK2 (IC50s = 8.3 and 30 nM, respectively).1 It is selective for ULK1 and ULK2 over a panel of 325 additional kinases at 10 µM but does inhibit serine/threonine kinase 17a (STK17A), also known as DRAK1, and MAP kinase-interacting serine/threonine protein kinase 2 (MNK2) (IC50s = 14 and 22 nM, respectively). ULK-101 inhibits nutrient starvation-induced phosphorylation of Beclin 1 in HEK293T cells (EC50 = 390 nM). It inhibits the formation of omegasomes positive for zinc finger FYVE-type containing 1 (ZFYVE1), also known as DFCP1, a marker of autophagy induction, in U2OS cells when used at a concentration of 5 µM. ULK-101 (1 and 2 µM) reduces the viability of nutrient-restricted H838, H727, H2030, and A549 lung cancer cells.
WARNING This product is not for human or veterinary use.
1. A potent and selective ULK1 inhibitor suppresses autophagy and sensitizes cancer cells to nutrient stress. iScience 8, 74-84 (2018).